Porton Pharma Solutions

Porton Pharma Solutions, established in 2005, is a key player in the pharmaceutical and healthcare sectors, specializing in the manufacturing and supply of drug intermediates and active pharmaceutical ingredients (APIs). Formerly known as Porton Fine Chemicals Ltd., the company officially adopted its current name in January 2018, reflecting its expanded focus. Operating primarily as a business-to-business (B2B) entity, Porton Pharma Solutions serves global pharmaceutical companies by providing critical components for drug development and production. Its product portfolio includes specialized offerings such as cell therapy ingredients and custom pharmaceutical manufacturing services, underscoring its role as a comprehensive solutions provider within the life sciences industry.

The company's operational scale is significant, supported by a workforce of 1,000-5,000 employees across its two primary locations. Porton Pharma Solutions offers extensive process development capabilities, alongside pilot and commercial-scale manufacturing services, enabling clients to advance their drug candidates from research to market. This integrated approach ensures efficiency and quality throughout the pharmaceutical supply chain. For insights into the dedicated professionals driving these operations, consider Meet Porton Pharma Solutions's team. The company's commitment to technical excellence and robust manufacturing infrastructure positions it as a reliable partner for pharmaceutical innovation.

With a reported revenue of $407.6M, Porton Pharma Solutions demonstrates substantial market presence and financial capacity within the competitive pharmaceutical manufacturing landscape. Headquartered in Chongqing, China, the company leverages its strategic location in Asia Pacific to serve a broad international client base. Its focus on high-value APIs and intermediates, coupled with advanced manufacturing services, aligns with the growing global demandView more...